Tesamorelin + Ipamorelin Blend (15 mg)
GH-axis blend (Tesamorelin + Ipamorelin) — 15 mg total
≥ 99.0% (component-wise for blends)CAS (blend — components have individual CAS numbers)Custom Blends & OEM
Overview
Blend combining the GHRH analog Tesamorelin with the GHSR-selective Ipamorelin for GH-axis research. Ratios are configurable; verify exact split per batch COA.
Specifications
- CAS
- (blend — components have individual CAS numbers)
- Purity (HPLC)
- ≥ 99.0% (component-wise for blends)
- Common vial sizes
- 15 mg
- MOQ
- On request
- Lead time
- 14–21 days
- Storage
- -20°C, protect from light
Documentation available on request
- Certificate of Analysis (COA)
- HPLC Chromatogram
- Mass-spec spectrum
- Stability data
- SDS / MSDS
- Sequence verification
Related peptides
Buyers who view Tesamorelin + Ipamorelin Blend (15 mg) also ask about:
Tesamorelin
GHRH analog · approved for HIV-associated lipodystrophy
- CAS
- 218949-48-5
- Vial
- 2 mg–20 mg
MOQ on requestGet quote →
Ipamorelin
Ghrelin / GHSR pathway GH-release peptide
- CAS
- 170851-70-4
- Vial
- 2 mg–10 mg
MOQ on requestGet quote →
CJC-1295 + Ipamorelin
GH-axis blend (CJC-1295 no DAC + Ipamorelin)
- CAS
- (blend)
- Vial
- 10 mg (5+5)
MOQ on requestGet quote →